Pamedoc
ActiveSummary
The computed 12-month bankruptcy probability of Pamedoc is 2.5% (moderate). The 2025 annual accounts show equity of €4,500 and a net result of €22,346. The figures fluctuate too strongly year-on-year for a reliable trend projection. The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
15-06
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
30-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Highest result from 2022 to 2025net €81,473 ▲25.6%
Operating result €100,181, net result €81,473, both a record.
31-12
Financial
Equity above €150,000equity €156,094 ▲109%
A profit in every financial year since 2022 builds equity to €156,094.
09-12
Gazette deed
Registered officeRegistered-office move2 facts ▸
Gazette deed
Registered office
Registered-office move2 facts ▸
- Board meeting, 21-10-2024
- Registered-office move, Plantin en Moretuslei 110 bus 001 te 2018 Antwerpen
01-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
05-06
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
05-10
Gazette deed
IncorporationAppointment: MERTENS Pauline (director) · Founder · Founding capital5 facts ▸
Gazette deed
Incorporation
Appointment: MERTENS Pauline (director) · Founder · Founding capital5 facts ▸
- Incorporation, 29-09-2022
- Founder, MERTENS Pauline (shareholder)
- Founding capital
- Other provision, “geen statutair bestuurder benoemd” (deed in Dutch)
- Director appointment, MERTENS Pauline (director (not named in the articles))
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
2 of 2 deeds read